Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 PatientsMartin Spahn, Chao‐Yu Hsu, Burkhard Kneitz et al.|European Urology|2010Cited by 154
Pretreatment Tables Predicting Pathologic Stage of Locally Advanced Prostate CancerSteven Joniau, Paolo Gontero, Martin Spahn et al.|European Urology|2014Cited by 38
Is there a prostate‐specific antigen upper limit for radical prostatectomy?Paolo Gontero, Steven Joniau, Martin Spahn et al.|British Journal of Urology|2011Cited by 25
The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional AnalysisMaria Schubert, Martin Spahn, Steven Joniau et al.|Advances in Urology|2012Cited by 9
1061 VALUE OF ELND IN LYMPH NODE NEGATIVE PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER IS UNCERTAINSteven Joniau, Martin Spahn, Paolo Gontero et al.|The Journal of Urology|2010Cited by 0